TALS Annual EBIT
-$76.48 M
-$28.97 M-60.98%
31 December 2022
Summary:
As of February 4, 2025, TALS annual earnings before interest & taxes is -$76.48 million, with the most recent change of -$28.97 million (-60.98%) on December 31, 2022. During the last 3 years, it has fallen by -$58.10 million (-316.13%).TALS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TALS Quarterly EBIT
-$10.11 M
+$9.48 M+48.39%
30 June 2023
Summary:
As of February 4, 2025, TALS quarterly earnings before interest & taxes is -$10.11 million, with the most recent change of +$9.48 million (+48.39%) on June 30, 2023. Over the past year, it has increased by +$8.30 million (+45.08%).TALS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TALS TTM EBIT
-$69.36 M
+$8.30 M+10.69%
30 June 2023
Summary:
As of February 4, 2025, TALS TTM earnings before interest & taxes is -$69.36 million, with the most recent change of +$8.30 million (+10.69%) on June 30, 2023. Over the past year, it has dropped by -$5.08 million (-7.91%).TALS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TALS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.0% | +45.1% | -7.9% |
| 3 y3 years | -316.1% | -113.5% | -614.2% |
| 5 y5 years | -316.1% | -103.3% | -1294.4% |
TALS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +324.9% | +113.5% | +1294.4% |
Talaris Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$10.11 M(-48.4%) | -$69.36 M(-10.7%) |
| Mar 2023 | - | -$19.60 M(-1.2%) | -$77.66 M(+1.5%) |
| Dec 2022 | -$76.48 M(+61.0%) | -$19.82 M(+0.0%) | -$76.48 M(+7.7%) |
| Sept 2022 | - | -$19.82 M(+7.6%) | -$71.04 M(+10.5%) |
| June 2022 | - | -$18.41 M(+0.0%) | -$64.27 M(+12.9%) |
| Mar 2022 | - | -$18.41 M(+28.0%) | -$56.92 M(+19.8%) |
| Dec 2021 | -$47.51 M | -$14.39 M(+10.2%) | -$47.51 M(+18.9%) |
| Sept 2021 | - | -$13.06 M(+18.1%) | -$39.95 M(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$11.06 M(+22.8%) | -$33.03 M(+23.7%) |
| Mar 2021 | - | -$9.01 M(+31.7%) | -$26.71 M(+17.8%) |
| Dec 2020 | -$22.68 M(+23.4%) | - | - |
| Dec 2020 | - | -$6.83 M(+11.4%) | -$22.68 M(+43.1%) |
| Sept 2020 | - | -$6.14 M(+29.6%) | -$15.85 M(+63.2%) |
| June 2020 | - | -$4.74 M(-4.8%) | -$9.71 M(+95.2%) |
| Mar 2020 | - | -$4.97 M | -$4.97 M |
| Dec 2019 | -$18.38 M | - | - |
FAQ
- What is Talaris Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Talaris Therapeutics?
- What is Talaris Therapeutics annual EBIT year-on-year change?
- What is Talaris Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Talaris Therapeutics?
- What is Talaris Therapeutics quarterly EBIT year-on-year change?
- What is Talaris Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Talaris Therapeutics?
- What is Talaris Therapeutics TTM EBIT year-on-year change?
What is Talaris Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TALS is -$76.48 M
What is the all time high annual EBIT for Talaris Therapeutics?
Talaris Therapeutics all-time high annual earnings before interest & taxes is -$18.00 M
What is Talaris Therapeutics annual EBIT year-on-year change?
Over the past year, TALS annual earnings before interest & taxes has changed by -$28.97 M (-60.98%)
What is Talaris Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TALS is -$10.11 M
What is the all time high quarterly EBIT for Talaris Therapeutics?
Talaris Therapeutics all-time high quarterly earnings before interest & taxes is -$4.74 M
What is Talaris Therapeutics quarterly EBIT year-on-year change?
Over the past year, TALS quarterly earnings before interest & taxes has changed by +$8.30 M (+45.08%)
What is Talaris Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TALS is -$69.36 M
What is the all time high TTM EBIT for Talaris Therapeutics?
Talaris Therapeutics all-time high TTM earnings before interest & taxes is -$4.97 M
What is Talaris Therapeutics TTM EBIT year-on-year change?
Over the past year, TALS TTM earnings before interest & taxes has changed by -$5.08 M (-7.91%)